Literature DB >> 7662983

Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features.

K Offit1, D C Louie, N Z Parsa, A Noy, R S Chaganti.   

Abstract

Deletions of the long arm of chromosome 7, previously documented in myelodysplasias and myeloid leukemias, have also been noted in lymphoid malignancies. Of 558 karyotypically abnormal specimens of non-Hodgkin's lymphoma (NHL) serially ascertained over an 8-year period, del(7q) was identified in 24 cases, 10 of which were of the small lymphocytic (sm lym) subtype. Del(7q) was the third most common karyotypic abnormality among the cohort of 61 sm lym cases in this ascertainment. Mapping of the deletions identified a region of common deletion affecting 7q32, which was the sole karyotypic abnormality in 2 cases. Eight of the ten sm lym cases were characterized by plasmacytoid features in histologic sections of lymphoma tumors or circulating cells in the peripheral blood. The del(7)(q32) was accompanied by 14q32-associated translocations in 11 of the 14 cases with histologies other than sm lym, compared with 2 of the sm lym cases. Extranodal involvement was more frequent in the del(7)(q32) sm lym NHLs, although median survival was typical of other low-grade lymphomas. These results suggest that loss or inactivation of a putative tumor-supressor gene at 7q32 may play a role the progression of lymphomas as well as constitute an early event in the pathogenesis of lymphoplasmacytoid tumors.

Entities:  

Mesh:

Year:  1995        PMID: 7662983

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.

Authors:  M Mateo; M Mollejo; R Villuendas; P Algara; M Sanchez-Beato; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.

Authors:  Xiaohui Bi; Meera Hameed; Neena Mirani; Erica Maria Pimenta; Jason Anari; Betsy J Barnes
Journal:  Breast Cancer Res       Date:  2011-11-04       Impact factor: 6.466

3.  Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.

Authors:  Xiaoying Qi; Xien Gui; Ke Zhuang
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.